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Objective: Aging is a major risk factor for osteoarthritis (OA). Forkhead-box class O (FoxO) transcription
factors regulate mechanisms of cellular aging, including protein quality control, autophagy and defenses
against oxidative stress. The objective of this study was to analyze FoxO transcription factors in normal,
aging and OA cartilage.
Design: Knee joints from humans ages 23e90 and from mice at the age of 4e24 months and following
surgically induced OA were analyzed for expression of FoxO proteins. Regulation of FoxO protein
expression and activation was analyzed in cultured chondrocytes.
Results: Human cartilage expressed FOXO1 and FOXO3 but not FOXO4 proteins. FOXO1 and FOXO3 were
more strongly expressed the superﬁcial and mid zone as compared to the deep zone and were mainly
localized in nuclei. During human joint aging, expression of FOXO1 and FOXO3 was markedly reduced in
the superﬁcial zone of cartilage regions exposed to maximal weight bearing. In OA cartilage, chondrocyte
clusters showed strong FOXO phosphorylation and cytoplasmic localization. Similar patterns of FOXO
expression in normal joints and changes in aging and OA were observed in mouse models. In cultured
chondrocytes, IL-1b and TNF-a suppressed FOXO1, while TGF-b and PDGF increased FOXO1 and FOXO3
expression. FOXO1 and FOXO3 phosphorylation was increased by IL-1b, PDGF, bFGF, IGF-1, and the
oxidant t-BHP.
Conclusions: Normal articular cartilage has a tissue speciﬁc signature of FoxO expression and activation
and this is profoundly altered in aging and OA in humans and mice. Changes in FoxO expression and
activation may be involved in cartilage aging and OA.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
The primary risk factor for osteoarthritis (OA) development is
aging, but the mechanisms by which aging contributes to OA sus-
ceptibility and progression remain to be investigated1.
The aging process, where oxygen radical production is increased
and oxidant defense mechanisms are compromised2e5, is accom-
panied by a progressive accumulation of damaged molecules and
organelles, leading to the decreased ability of cells to functiono: M.K. Lotz, Department of
e Scripps Research Institute,
SA.
i), ort171@poh.osaka-med.ac.
ra@scripps.edu (H. Asahara),
choate@scripps.edu, mlotz@
s Research Society International. Pnormally6. Therefore, protein quality control mechanisms are
essential in maintaining normal biosynthetic cell functions and
their failure plays an important role in the pathogenesis of age-
related disease7,8. One of the prominent pathways involved in
turnover of cellular constituents is autophagy. Compromised
autophagy associated with a reduction and loss of ULK1, Beclin1,
and LC3 expressionwas observed in human OA and age-related and
surgically induced OA in mice9.
One of the major signaling pathways that regulate cellular aging
and stress resistance is the Insulin/IGF-1 signaling pathway. The
protein kinase Akt is an important upstream signaling component
in this pathway that regulates diverse cellular functions related to
longevity, cellular senescence, and metabolism. Among of the most
evolutionarily conserved targets of Akt are the forkhead-box class O
(FOXO) transcription factors10,11. The mammalian FOXO family
consists of three members, FOXO1, FOXO3, and FOXO412,13. Activity
of the three FOXO molecules is controlled by phosphorylation,ublished by Elsevier Ltd. All rights reserved.
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phorylates FOXO1, FOXO3, and FOXO4 at three conserved sites,
resulting in nuclear export and subsequent degradation14.
FOXOs regulate not only genes governing oxidative defense such
asMnSOD, catalase, and theDNArepair enzymeGADD4515,16 but also
regulate protein degradation mediated by the ubiquitineprotea-
some system17 and the autophagic/lysosomal pathway18. Abnormal
expression and activation of FOXOs is involved in the pathogenesis of
age-related diseases affecting bone19, muscle20, and CNS21.
Importantly, expression and activation of FOXO transcriptional
factors are highly context and cell-lineage speciﬁc19e21. The ob-
jectives of this study were to analyze protein expression and acti-
vation of FOXO transcription factors in normal cartilage and to
determine changes in aging and OA.
Methods
Human knee joints
Human knee joints from individuals ages 23e90 were obtained
at autopsy under approval by the Scripps Human Subjects Com-
mittee. The entire femoral condyles of young normal knee joints
were harvested from six donors (age 23e48 years,
mean  SD ¼ 36.0  9.6, OA grade I, Mankin score ¼ 0) having no
history of joint disease. Aged normal knee joints were also obtained
at autopsy from four donors having no history of joint diseases or
overt OA (age 68 to 76, mean  SD ¼ 72.5  3.6, OA grade IeII,
Mankin score ¼ 1e3). Human OA joints were obtained from four
donors (age from 64 to 90, mean  SD ¼ 81.5  10.3, OA grade IIIe
IV, Mankin score ¼ 7e8). Articular surfaces were graded macro-
scopically according to a modiﬁed Outerbridge scale22. Osteo-
chondral slabs (5 mm thickness) were harvested from the central
part of medial femoral condyle for histomorphologic analysis.
Subsequently, the slabs were cut into six tissue blocks from the
anterior to the posterior condyle [Fig. 1(B)]. Each block was ﬁxed in
10% zinc-buffered formalin for 2 days, decalciﬁed in TBD-2 for 7
days, followed by parafﬁn embedding. Serial sections (4 mm each)Fig. 1. FOXO protein expression in human articular cartilage. A. Protein extracts from articul
Graph shows the results of a total of ﬁve normal and ﬁve OA donors. B. Photograph of osteoch
were used to cut sections from the most proximal (1) to the most distal (6) location. C.
correspond to the regions in panel B. Magniﬁcation 40.were cut, stained with Safranin O-fast green, and graded according
to Mankin scoring system23.
Cell and protein isolation from human cartilage
Human chondrocytes were isolated and cultured as described
previously24. For protein isolation directly from cartilage tissue, the
cartilage strips obtained from patients undergoing total knee
arthroplasty were separated based on the extent of degradation
and frozen in liquid nitrogen. Normal cartilage samples were
collected from young donors having no history of joint disease. The
frozen tissues were crushed and homogenized. Samples were
incubated in TRIzol (Invitrogen) at room temperature. After addi-
tion of chloroform, samples were vortexed vigorously and centri-
fuged for 15 min at 12,000 g at 4C. The interphase and organic
phase was collected, followed by addition of 100% ethanol. After
centrifugation, the supernatant was collected for protein isolation.
Proteins were precipitated by the addition of isopropanol and
diluted in 6M Urea, 2% SDS.
Human chondrocyte cultures
The isolated chondrocytes were plated at high density in DMEM
with 10% CS and antibiotics and allowed to attach to the culture
ﬂasks. The cells were incubated at 37C in a humidiﬁed gas mixture
containing 5% of CO2 balanced with air. The chondrocytes were
used in the experiments at conﬂuence (2e3 weeks in primary
culture).
Human chondrocytes were seeded in six-well plates at a density
of 4.0  105 cells/well. After 1 day, the cells were washed and
incubated in DMEM with 0.5% CS for 24 h. Cytokines, growth fac-
tors, tert-Butyl hydroperoxide (t-BHP), and CS were added at the
following ﬁnal concentrations: IL-1b (1 ng/ml), TNF-a (10 ng/ml),
IL-6 (10 ng/ml), TGF-b1 (10 ng/ml), BMP-7 (100 ng/ml), bFGF2
(25 ng/ml), PDGF-AA (25 ng/ml), IGF-1 (100 ng/ml), t-BHP (25 mM
and 250 mM), and 10% CS. Cells were harvested after 30min, 60min,
1 day, 2 days, and 5 days of incubation.ar cartilage were analyzed by western blotting using antibodies to FOXOs as indicated.
ondral slab from the central region of the medial femoral condyle showing regions that
Immunohistochemistry was performed for FOXO1 and FOXO3. Numbers of sections
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All animal experiments were performed according to protocols
approved by the Institutional Animal Care and Use Committee
(IACUC) at The Scripps Research Institute. In the spontaneous
aging-related OA model, C57BL/6J mice were kept under normal
conditions and knee joints were collected at 4, 12 and 24months of
age. The surgical OA model was induced in 4 months old C57BL/6J
mice by transection of the medial meniscotibial ligament and the
medial collateral ligament (MMTL þ MCL) as described25 and ani-
mals were euthanized 10 weeks later.
Knee joints from both murine models were resected from both
hind legs, ﬁxed in 10% zinc-buffered formalin for 2 days, decalciﬁed
in TBD-2 for 24 h. Serial sections (4 mm each) were cut, and expres-
sion of FoxO proteins was analyzed by immunohistochemistry.Immunohistochemistry
For antigen unmasking, the tissue sections were incubated with
2.5 mg/ml of hyaluronidase for 60 min at 37C. After washing withFig. 2. Zonal distribution of total and phospho-FOXO in human articular cartilage. Cartilage
bodies to total FOXO and phospho-FOXO. Representative images for nuclear and cytoplasmic
localization are 100, for zonal distribution is 10 magniﬁcation. Results are shown as % po
quartile. Data are representative of six normal donors.* ¼ P < 0.05 vs each zone; & ¼ P <phosphate buffered saline (PBS), sections were blocked with 10%
goat serum for 1 h at room temperature. This condition was ob-
tained after optimization and provided speciﬁc positive staining
without non-speciﬁc signals. Anti-FOXO1A (1:50 dilution), Anti-
FOXO1A (phospho S256) (1:100 dilution), Anti-FOXO3A (1:100
dilution), Anti-FOXO3A (phospho S253) (1:100 dilution), and
negative control rabbit IgG (1 mg/ml) were applied with 0.1% Tween
20 and incubated overnight at 4C. All primary antibodies were
purchased from Abcam. Incubation with secondary antibody, sub-
strate and hematoxylin were performed as described9 [Fig. 1(C)].Quantiﬁcation and localization of positive cells in human cartilage
FOXO localization in each cartilage zone was assessed system-
atically by counting positive cells in three pictures under 40
magniﬁcation starting from the cartilage surface to the deep zone9.
The identiﬁcation of each zone [Fig. 2(A)] was based on previously
reported characteristics that comprise cell shape, morphology,
orientation, and pericellular matrix deposition26. The percentages
of positive cells for total FOXO and phosphorylated FOXO weresections from maximal and minimal weight bearing regions were stained with anti-
localization of FOXO1 and zonal distribution are shown in panel A. Images for cellular
sitive cells for FOXO1 in panel B and for FOXO3 in panel C. Values are the median and
0.05 vs maximal weight bearing.
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ted as positive for cytoplasmic p-FOXO when staining was pre-
dominantly cytoplasmic positive staining on sections that were
counter-stained with hematoxylin [Fig. 2(A)]. The frequency of
positive cells was expressed as a percentage relative to the total
number of cells counted in each zone.
Quantiﬁcation of FoxO immunoreactivity in mouse knee joints
Cartilage cellularity in C57BL/6J micewas quantiﬁed by counting
the chondrocytes in a microscopic ﬁeld27. Three pictures were
taken under 40 magniﬁcation, representing the center of the
femoral condyle that is not covered by the meniscus as well as the
anterior and posterior femoral condyles covered by the meniscus.
Then, the total numbers of cells and FoxO positive cells were
counted in each section.
Quantitative western blotting
Quantitative western blotting was performed with the LiCor
immunoﬂuorescence detection system (Licor, Lincoln, NE). Primary
antibodies from Cell Signaling were used: Anti-FOXO1A (1:1000
dilution), Anti-FOXO1A (phospho S256) (1:1000 dilution), Anti-
FOXO3A (1:1000 dilution), Anti-FOXO3A (phospho S253) (1:1000
dilution), Anti-Akt (phospho S473) (1:1000 dilution), and GAPDH
(1:5000) in 1/2 Odyssey buffer in PBS with 0.1% Tween 20. After
washing in TBST, secondary antibodies goat anti-rabbite IRDye 800
(1:5000 dilution) for FOXOs and goat anti mouse e IRDye 680
(1:10,000 dilution) for GAPDH, diluted in 1/2 Odyssey buffer in
PBS with 0.1% Tween 20 and 0.01% SDS, were applied. Blots were
washed in PBS and then water before acquisition on the LiCor
Odyssey. In-lane background was removed (Median: Top/Bottom)
before analysis with the Odyssey software version 3.0 (LiCor). In-
tegrated intensity values (K counts) for each protein of interest
were normalized to those of GAPDH.
Statistical analysis
Statistically signiﬁcant differences between three groups were
determined with Kruskal Wallis H-test and Friedman test. When a
signiﬁcant differences were found among three groups, Manne
Whitney U test andWilcoxon signed-rank test were used to analyze
the speciﬁc sample pairs for signiﬁcant differences. The results are
reported as median and quartile 25%e75%. P values less than 0.05
were considered signiﬁcant.
Results
FOXO protein expression in young normal human cartilage
Articular cartilage from normal human knee joints expressed
predominantly FOXO1 and FOXO3 proteins but not FOXO4 as
detected by western blotting [Fig. 1(A)]. Both non-ﬁbrillated and
ﬁbrillated OA cartilage showed signiﬁcant FOXO1 and FOXO3
reduction compared to normal cartilage [Fig. 1(A)]. Immunohisto-
chemistry was used to determine the distribution and phosphor-
ylation of FOXO1 and FOXO3. Locations in the knee joint differ in
regard to exposure of articular cartilage to weight bearing and
susceptibility to OA. To determine regional changes in FOXO protein
expression, adjacent cartilage sections representing the entire
femoral condyle (n ¼ 6 per condyle) were analyzed [Fig. 1(B)]. The
most proximal and the most distal sections (#1 or 2 and # 5 or 6)
are exposed to minimal, while the central sections (#3 or 4) are
exposed to maximal weight bearing [Fig. 1(C)]. We also assessed
differences in FOXO among the superﬁcial, mid and deep zone[Fig. 2(A)]. FOXO1 and FOXO3 proteins (n ¼ 6 donors each) were
more highly expressed in the superﬁcial and middle than the deep
zone [Fig. 2(B), (C)]. When determining nuclear/cytoplasmic
localization with FOXO by counter-staining of hematoxylin, FOXO1
and FOXO3 were found mainly in the nuclei [Fig. 2(B), (C)]. Com-
parison of areas of cartilage exposed to minimal vs maximal weight
bearing showed that FOXO3 protein in the deep zone was more
strongly expressed in areas exposed to minimal weight bearing.
Phosphorylated FOXO1 and FOXO3 (n ¼ 6 donors each) were
detected at higher levels in the superﬁcial and middle zones as
compared to the deep zone. The levels of total FOXO proteins and
phosphorylated FOXOs were signiﬁcantly greater in the nucleus as
compared to cytoplasm [Fig. 2(B), (C)].
In summary, among the FOXO isoforms, FOXO1 and FOXO3
proteins are most strongly expressed in normal cartilage. Overall,
their protein expression is higher in the superﬁcial andmiddle zone
as compared to deep zone. In regard to regional differences, only
FOXO3 protein in the deep zone was more strongly expressed in
areas exposed to minimal weight bearing. Nuclear localization of
FOXO proteins indicates that most cells in the superﬁcial and mid
zone express activated FOXO1 and FOXO3 proteins.
Aging and OA-associated changes in FOXO protein expression in
human cartilage
For the analysis of aging and OA cartilage, we selected repre-
sentative maximal weight bearing regions [#3 or as shown in
Fig. 1(B)]. OA cartilage had no superﬁcial zone in maximal weight
bearing areas.
In aged donors, FOXO1 and FOXO3 (n ¼ 4 donors each) were
signiﬁcantly decreased in the superﬁcial zone compared with young
normalcartilage (Fig. 3). Incontrast, FOXO1andFOXO3inOAcartilage
(n ¼ 4 donors each) were signiﬁcantly increased in the middle zone
compared with normal cartilage. In terms of nuclear/cytoplasmic
localization, FOXO1 and FOXO3 in the middle zone of OA cartilage
were stronger in the cytoplasm compared with normal cartilage
[Fig. 3(B)]. Moreover, phosphorylated FOXO1 and FOXO3 were
signiﬁcantly stronger in the middle zone compared with normal
cartilage. This increase was due to the cell clusters localized in the
middle zone inOAcartilage (Fig. 3). These cell clusters showed strong
protein expression and phosphorylation of FOXO1 and FOXO3. These
results indicate an age-related reduction in FOXO1 and FOXO3 pro-
teinexpression in the superﬁcial zoneand increasedphosphorylation
and cytoplasmic localization in the OA cluster chondrocytes.
FoxO protein expression in normal, aging and OA mouse cartilage
Two different types of OA models in mice were used, including
aging-related OA and mechanical overload induced OA in order to
mitigate their limitations and to correlate with aging and OA-
related changes in human knee cartilage. Both mouse models
showed cartilage degradation with only small variations in OA
severity.
Normal joints from skeletallymature 4-month-old C57BL/6Jmice
showed high levels of FoxO1 and FoxO3 proteins in the superﬁcial
and upper middle zones. FoxO1 and FoxO3 were localized mainly
in the nucleus. The signals for the phosphorylated FoxOs were less
intense as compared to the total FoxOs in 4-month-old mice. At the
ages of 12 months and 24 months, there was a signiﬁcant aging-
related reduction in FoxO1- and FoxO3-positive cells compared
with 4-month-old mice, as well as a signiﬁcant reduction in FoxO1
and FoxO3 in 24-month-old mice compared with 12-month-old
mice [Fig. 4(B)]. In 12- and 24-month-old mice, the reduction of
FoxO protein was more marked in the meniscus non-covered re-
gions compared to the meniscus-covered regions [Fig. 4(A)].
Fig. 3. Changes in FOXO protein expression in human cartilage from aging and OA-affected joints. A. Cartilage was collected from the femoral condyles of normal (weight bearing
regions) and OA knee joints and analyzed by immunohistochemistry with antibodies as indicated. Images are 40, insets on the right are 100 magniﬁcation. B. Quantiﬁcation of
total FOXO, phospho-FOXO in cartilage zones and cytoplasmic vs nuclear localization (shown as % cytoplasmic localization). Data are representative of six young, four aged and four
OA donors.
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of FoxO1-positive cells andFoxO3-positive cells comparedwithnon-
operated 4-month-old mice. The quantitative analysis of positive
cells showed a signiﬁcant reduction of FoxO1 and FoxO3 10 weeks
after surgery. In contrast, the cluster-like chondrocyte aggregates in
ﬁbrillated lesions, showed strong expression of FoxO1 and FoxO3
protein and also of the phosphorylated forms of FoxO1 and FoxO3.
Regulation of FOXO protein expression and activation in cultured
human chondrocytes
In cultured human chondrocytes, FOXO1 and FOXO3 proteins
were basally expressed, whereas FOXO4 was expressed to a lesser
extent. IL-1b and TNF-a signiﬁcantly repressed FOXO1 at 2 and 5
days. FOXO3 protein expressionwas also reduced by IL-1b at 5 days,
but to a lesser extent by TNF-a. On the other hand, stimulationwith
TGF-b1 signiﬁcantly increased FOXO1 protein at 2 days. FOXO3 was
also increased 2 days and 5 days after the addition of PDGF (Fig. 5).
Shorter treatment periods (30 mine48 h) did not signiﬁcantly
affect expression of the FOXO proteins.
Phosphorylation of FOXO1, FOXO3, and FOXO4 increased in
chondrocytes stimulated with IL-1b, TNF-a, bFGF, PDGF, t-BHP, and
serum (Fig. 6). We used antibodies directed against phospho-serine
256 of FOXO1 (which cross-react with FOXO4) or antibodies against
phospho-serine 253 of FOXO3. These conserved sites are phos-
phorylated by Akt, which was also activated in chondrocytes upon
these stimuli, as judged from blots with the Akt anti-phospho-
serine 473 antibody (Fig. 6).Discussion
The present study is the ﬁrst to elucidate the characteristics of
the protein expression and activation of FOXO transcription fac-
tors in articular cartilage. Our results demonstrated that among
three FOXOs, FOXO1 and FOXO3 proteins were highly expressed
in normal human and mouse cartilage, suggesting that they play
important roles in cartilage homeostasis. FOXO protein expres-
sion showed differences among cartilage zones with higher
expression in superﬁcial and middle zones compared to the deep
zone. These ﬁndings are consistent with observations that
MnSOD, one of the major FOXO target antioxidants, was abun-
dantly expressed in the superﬁcial but not in the deep zone of
human cartilage5.
In aged human cartilage, the protein expression of FOXO tran-
scription factors was signiﬁcantly decreased in the superﬁcial
zone of regions exposed to maximal weight bearing. Similarly, in
mouse knee joints there was an age-related reduction of FOXO
positive cells especially in the meniscus non-covered regions. In
bone, FoxO1 expression also progressively decreased with aging,
whereas FoxO3 and FoxO4 levels remained stable19. In muscle, the
aging-related dramatic decrease of the nuclear FoxO1 and FoxO3
was associated with muscle atrophy28. In the present study, we
observed increased FOXO positive cells in the middle zone of hu-
man OA cartilage and in ﬁbrillated areas and osteophytes in mouse
knees. Importantly, the cellular localization of FOXO in OA cartilage
was predominantly in the cytoplasm in contrast to normal carti-
lage, indicating inactivation of FOXO transcription factors. The
Fig. 4. FoxO protein expression in normal, aging and OA-affected mouse joints. Knee joints were collected from C57/Bl6 mice at the indicated ages or 10 weeks following induction
of experimental OA by surgical knee destabilization. A. Representative images normal young, aging and experimental OA cartilage. Images are 10, insets are 40magniﬁcation. B.
Quantiﬁcation of total FoxO, phospho-FoxO and cytoplasmic localization. Data represent four mice per time point and three for surgical OA.
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are abnormally activated and differentiated29.
Cell density and composition in OA cartilage are different as
compared to normal tissue. Cell density is reduced in some areasFig. 5. Changes in FOXO protein expression in response to stimulation of cultured human ch
were analyzed by western blotting with the antibodies indicated. Representative western b
different experiments using cells from different donors, each including all stimuli and timebut in ﬁbrillated areas there are chondrocyte clusters, which
represent a different cell phenotype as compared to the normal
zone-speciﬁc chondrocytes. In non-weight bearing areas of carti-
lage from OA joints where the superﬁcial zone is still present andondrocytes. Cells were treated with the indicated stimuli for 2 or 5 days and cell lysates
lot images are shown and graphs represent quantiﬁcation of western blots from three
points.
Fig. 6. Changes in FOXO phosphorylation in response to stimulation of cultured human chondrocytes. Cells were treated with the indicated stimuli for 60 min and cell lysates were
analyzed by western blotting with the antibodies for phosphorylated FOXOs and Akt as indicated. Representative western blot images are shown and graphs represent quanti-
ﬁcation of western blots from ﬁve different experiments using cells from different donors, each including all stimuli.
Y. Akasaki et al. / Osteoarthritis and Cartilage 22 (2014) 162e170168there are no ﬁbrillations, there is a reduction in the total number of
cells, in the total number of FOXO positive cells and in the per-
centage of FOXO positive cells.
The activity of FOXOs is tightly controlled by a phosphorylation-
dependent shuttling system that modulates their cellular localiza-
tion10 and this is predominantly controlled by the Insulin/IGF-1
pathway acting through PI3K and Akt-mediated phosphorylation
of FOXO. Phosphorylation of FOXOs by Akt provokes their nuclear
export. In this study, we observed signiﬁcantly higher levels of
phosphorylated FOXOs in the cytoplasm of OA cartilage compared
to normal cartilage. High levels of IGF-1 and IGF-1 receptor have
been found in human OA cartilage, especially in chondrocytes of the
upper zone30e32. However, the superﬁcial zone of normal cartilage
had reduced IGF-1 receptor levels30 and IGF-induced activation of
Akt activation is reduced in OA chondrocytes33. These prior obser-
vations suggest a similar pattern that may be mechanistically
related to the speciﬁc distribution of phosphorylated FOXOs seen in
this study. Mechanical load is an alternative mechanism for dys-
regulated FOXOs in OA cartilage, as shear stress downregulated
FOXO DNA-binding activity by Akt activation in muscle28.
In cultured normal chondrocytes IL-1b and TNF-a reduced
FOXOs protein expression, and increased phosphorylation of
FOXOs. This observation is similar to synovial cells where FOXO1
and FOXO4 were phosphorylated following stimulation with IL-1b
and TNF-a34. Therefore, proinﬂammatory cytokines appear to
inhibit the activity of FOXOs. On the other hand, our results showed
that TGF-b up-regulated FOXO1 protein expression but did notaffect phosphorylation, whereas PDGF up-regulated FOXO3 and
increased phosphorylation of all FOXOs. PDGF was reported to
induce the phosphorylation and inactivation of FOXO protein in
hepatic stellate cells35, in ﬁbroblasts36,37, and in vascular smooth
muscle cells38. PDGF, FGF, and IGF-I also repressed the expression of
FOXO genes in human ﬁbroblasts36.
Increased intracellular ROS was reported to facilitate the local-
ization of FOXO to the nucleus where it is transcriptionally active39.
Upon treatment with H2O2, c-Jun-N-terminal kinase (JNK) phos-
phorylates FOXO at two threonine residues (Thr447 and Thr451 in
FOXO4), which are different from the Akt phosphorylation sites,
resulting in increased nuclear localization and activation of tran-
scriptional activity39e42. In contrast, oxidative stress can increase
Akt activity and subsequent FOXO phosphorylation, dependent on
the cellular context. Our results in cultured chondrocytes stimu-
lated with t-BHP showed FOXO phosphorylation (serine 256 of
FOXO1 and serine 253 of FOXO3). The opposing forces of Akt vs JNK
signaling are considered to determine whether FOXO will direct a
transcriptional response regulating entry into quiescence or
senescence43. To address functions of FOXO and phosphorylated
FOXO in chondrocytes, further studies with manipulating FOXO
expression are needed.
In summary, the present results suggest that attenuated FOXO
protein expression or altered FOXO activation may represent a
novel mechanism in the development of OA. In view of their central
function in aging, FOXO proteins may provide a potential molecular
target for the treatment of OA.
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